LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens.

Popova, M / Molimard, P / Courau, S / Crociani, J / Dufour, C / Le Vacon, F / Carton, T

Journal of applied microbiology

2012  Volume 113, Issue 6, Page(s) 1305–1318

Abstract: ... cells. Consequently, they can directly antagonize pathogens and thus exert beneficial effects ... used as preventive and therapeutic agents in upper respiratory tract infections (URTIs) and otitis ... Probiotics are live micro-organisms with beneficial effects on human health, which have the ability ...

Abstract Probiotics are live micro-organisms with beneficial effects on human health, which have the ability to counteract infections at different locations of the body. Clinical trials have shown that probiotics can be used as preventive and therapeutic agents in upper respiratory tract infections (URTIs) and otitis. Their mechanical properties allow them to aggregate and to compete with pathogens for nutrients, space and attachment to host cells. Consequently, they can directly antagonize pathogens and thus exert beneficial effects without directly affecting the metabolism of the host. An overview of the probiotics with such traits, tested up to date in clinical trials for the prevention or treatment of URTIs and otitis, is presented in this review. Their mechanical properties in the respiratory tract as well as at other locations are also cited. Species with interesting in vitro properties towards pharyngeal cells or against common respiratory pathogens have also been included. The potential safety risks of the cited species are then discussed. This review could be of help in the screening of probiotic strains with specific mechanical properties susceptible to have positive effects in clinical trials against URTIs.
MeSH term(s) Antibiosis ; Bacterial Adhesion ; Bifidobacterium ; Clinical Trials as Topic ; Humans ; Lactobacillus ; Otitis/therapy ; Probiotics/therapeutic use ; Respiratory System/microbiology ; Respiratory Tract Infections/therapy ; Streptococcus
Keywords covid19
Language English
Publishing date 2012-08-03
Publishing country England
Document type Journal Article ; Review
ZDB-ID 1358023-1
ISSN 1365-2672 ; 1364-5072
ISSN (online) 1365-2672
ISSN 1364-5072
DOI 10.1111/j.1365-2672.2012.05394.x
Shelf mark
Zs.A 259: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top